A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels

J Ethnopharmacol. 2024 Aug 10:330:118218. doi: 10.1016/j.jep.2024.118218. Epub 2024 Apr 25.

Abstract

Ethnopharmacology relevance: Zanthoxylum bungeanum Maxim. (Z. bungeanum), a member of the Rutaceae family, has a rich history of traditional use in Asia for treating arthritis and toothache conditions. As characteristic chemical components, numerous kinds of alkaloids have been extracted from plants and their diverse biological activities have been reported. However, research on the isoquinoline alkaloid, a specific type of alkaloids, in Z. bungeanum was scarce.

Aim of the study: The study aimed to isolate a novel isoquinoline alkaloid from Z. bungeanum and explore its pharmacological activity in vitro and analgesic activity in vivo.

Materials and methods: Isoquinoline alkaloid isolation and identification from Z. bungeanum were conducted using chromatographic and spectroscopic methods. The whole-cell patch-clamp technique was applied to assess its impact on neuronal excitability, and endogenous voltage-gated potassium (Kv) and sodium (Nav) currents in acutely isolated mouse small-diameter dorsal root ganglion (DRG) neurons. Its inhibitory impacts on channels were further validated with HEK293 cells stably expressing Nav1.7 and Nav1.8, and Chinese hamster ovary (CHO) cells transiently expressing Kv2.1. The formalin inflammatory pain model was utilized to evaluate the potential analgesic activity in vivo.

Results: A novel isoquinoline alkaloid named HJ-69 (N-13-(3-methoxyprop-1-yl)rutaecarpine) was isolated and identified from Z. bungeanum for the first time. HJ-69 significantly suppressed the firing frequency and amplitudes of action potentials in DRG neurons. Consistently, it state-dependently inhibited endogenous Nav currents of DRG neurons, with half maximal inhibitory concentration (IC50) values of 13.06 ± 2.06 μM and 30.19 ± 2.07 μM for the inactivated and resting states, respectively. HJ-69 significantly suppressed potassium currents in DRG neurons, which notably inhibited the delayed rectifier potassium (IK) currents (IC50 = 6.95 ± 1.29 μM) and slightly affected the transient outward potassium (IA) currents (IC50 = 523.50 ± 39.16 μM). Furtherly, HJ-69 exhibited similar potencies on heterologously expressed Nav1.7, Nav1.8, and Kv2.1 channels, which correspondingly represent the main components in neurons. Notably, intraperitoneal administration of 30 mg/kg and 100 mg/kg HJ-69 significantly alleviated pain behaviors in the mouse inflammatory pain model induced by formalin.

Conclusion: The study concluded that HJ-69 is a novel and active isoquinoline alkaloid, and the inhibition of Nav and Kv channels contributes to its analgesic activity. HJ-69 may be a promising prototype for future analgesic drug discovery based on the isoquinoline alkaloid.

Keywords: HJ-69; Inflammatory pain; Isoquinoline alkaloid; Kv; Nav; Zanthoxylum bungeanum.

MeSH terms

  • Alkaloids / chemistry
  • Alkaloids / isolation & purification
  • Alkaloids / pharmacology
  • Alkaloids / therapeutic use
  • Analgesics* / chemistry
  • Analgesics* / isolation & purification
  • Analgesics* / pharmacology
  • Analgesics* / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology
  • Cricetulus
  • Ganglia, Spinal* / drug effects
  • Ganglia, Spinal* / metabolism
  • HEK293 Cells
  • Humans
  • Inflammation / drug therapy
  • Isoquinolines / chemistry
  • Isoquinolines / isolation & purification
  • Isoquinolines / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NAV1.7 Voltage-Gated Sodium Channel / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Pain* / drug therapy
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Voltage-Gated / drug effects
  • Potassium Channels, Voltage-Gated / metabolism
  • Voltage-Gated Sodium Channel Blockers / isolation & purification
  • Voltage-Gated Sodium Channel Blockers / pharmacology
  • Zanthoxylum* / chemistry

Substances

  • Analgesics
  • Isoquinolines
  • Alkaloids
  • Potassium Channel Blockers
  • NAV1.7 Voltage-Gated Sodium Channel
  • Voltage-Gated Sodium Channel Blockers
  • Potassium Channels, Voltage-Gated
  • Anti-Inflammatory Agents
  • Scn9a protein, mouse